Abstract:Type III collagen (Col3), a fibril-forming collagen, is a major extracellular matrix component in a variety of internal organs and skin. It is also expressed at high levels during embryonic skeletal development and is expressed by osteoblasts in mature bone. Loss of function mutations in the gene encoding Col3 (Col3a1) are associated with vascular Ehlers–Danlos syndrome (EDS). Although the most significant clinical consequences of this syndrome are associated with catastrophic failure and impaired healing of soft tissues, several studies have documented skeletal abnormalities in vascular EDS patients. However, there are no reports of the role of Col3 deficiency on the murine skeleton. We compared craniofacial and skeletal phenotypes in young (6–8 weeks) and middle-aged (>1 year) control (Col3+/+) and haploinsufficient (Col3+/−) mice, as well as young null (Col3−/−) mice by microcomputed tomography (μCT). Although Col3+/− mice did not have significant craniofacial abnormalities based upon cranial morphometrics, μCT analysis of distal femur trabecular bone demonstrated significant reductions in bone volume (BV), bone volume fraction (BV/TV), connectivity density, structure model index and trabecular thickness in young adult female Col3+/− mice relative to wild-type littermates. The reduction in BV/TV persisted in female mice at 1 year of age. Next, we evaluated the role of Col3 in vitro. Osteogenesis assays revealed that cultures of mesenchymal progenitors collected from Col3−/− embryos display decreased alkaline phosphatase activity and reduced capacity to undergo mineralization. Consistent with this data, a reduction in expression of osteogenic markers (type I collagen, osteocalcin and bone sialoprotein) correlates with reduced bone Col3 expression in Col3+/− mice and with age in vivo. A small but significant reduction in osteoclast numbers was found in Col3+/− compared to Col3+/+ bones. Taken together, these findings indicate that Col3 plays a role in development of trabecular bone through its effects on osteoblast differentiation.

Type 1 collagen: Synthesis, structure and key functions in bone mineralization

Collagens and collagen-related diseases

Mutations in collagen genes: causes of rare and some common diseases in humans

Type-I collagen produced by distinct fibroblast lineages reveals specific function during embryogenesis and Osteogenesis Imperfecta

Collagens—structure, function, and biosynthesis

Collagen formation, function and role in kidney disease

Collagen Structure-Function Mapping Informs Applications for Regenerative Medicine

Advances in the study of cartilaginous type X collagen

Collagen structure and functional implications

Collagen: quantification, biomechanics and role of minor subtypes in cartilage

Type III Collagen Regulates Osteoblastogenesis and the Quantity of Trabecular Bone

A Comprehensive Review on Collagen Type I Development of Biomaterials for Tissue Engineering: From Biosynthesis to Bioscaffold

Basement membrane collagens and disease mechanisms

From Structure to Phenotype: Impact of Collagen Alterations on Human Health

Recent Progress in Osteogenesis Imperfecta

Regulation of Collagen I and Collagen III in Tissue Injury and Regeneration

Collagen-based biomaterials for biomedical applications.

Reviewing the Regulators of COL1A1

Current concepts in osteogenesis imperfecta: Bone structure, biomechanics and medical management

Molecular and structural mapping of collagen fibril interactions